Cargando…

Lifelong Prophylaxis With Trimethoprim-Sulfamethoxazole for Prevention of Outbreak of Pneumocystis jirovecii Pneumonia in Kidney Transplant Recipients

BACKGROUND: Outbreaks of Pneumocystis jirovecii pneumonia (PCP) in kidney transplant recipients are frequently reported worldwide. However, the general guidelines propose only short-term prophylaxis with trimethoprim-sulfamethoxazole after kidney transplantation. We experienced 3 PCP outbreaks in th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Goto, Norihiko, Takahashi-Nakazato, Ai, Futamura, Kenta, Okada, Manabu, Yamamoto, Takayuki, Tsujita, Makoto, Hiramitsu, Takahisa, Narumi, Shunji, Tsuchiya, Kiyoto, Gatanaga, Hiroyuki, Watarai, Yoshihiko, Oka, Shinichi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2017
Materias:	Kidney Transplantation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5441982/ https://www.ncbi.nlm.nih.gov/pubmed/28573186 http://dx.doi.org/10.1097/TXD.0000000000000665

Ejemplares similares

Management of Pneumocystis jirovecii Pneumonia in Kidney Transplantation to Prevent Further Outbreak
por: Goto, Norihiko, et al.
Publicado: (2015)

A Case of Pneumonia Caused by Pneumocystis jirovecii Resistant to Trimethoprim-Sulfamethoxazole
por: Lee, Sang Min, et al.
Publicado: (2015)

Impact of grafting using thin upper pole artery ligation on living-donor adult kidney transplantation: The STROBE study
por: Hiramitsu, Takahisa, et al.
Publicado: (2016)

Safety and efficacy of prophylaxis for Pneumocystis jirovecii pneumonia involving trimethoprim-sulfamethoxazole dose reduction in kidney transplantation
por: Prasad, G. V. Ramesh, et al.
Publicado: (2019)

Efficacy of Low-Dose Trimethoprim/Sulfamethoxazole for the Treatment of Pneumocystis jirovecii Pneumonia in Deceased Donor Kidney Recipients
por: Ji, Jianlei, et al.
Publicado: (2021)

Trimethoprim-Sulfamethoxazole (Bactrim) Dose Optimization in Pneumocystis jirovecii Pneumonia (PCP) Management: A Systematic Review
por: Haseeb, Abdul, et al.
Publicado: (2022)

Impact of Arterial Reconstruction With Recipient's Own Internal Iliac Artery for Multiple Graft Arteries on Living Donor Kidney Transplantation: Strobe Study
por: Hiramitsu, Takahisa, et al.
Publicado: (2015)

Hypercalcaemia preceding diagnosis of Pneumocystis jirovecii pneumonia in renal transplant recipients
por: Ling, Jonathan, et al.
Publicado: (2017)

Treatment With Reduced-Dose Trimethoprim-Sulfamethoxazole Is Effective in Mild to Moderate Pneumocystis jirovecii Pneumonia in Patients With Hematologic Malignancies
por: Hammarström, Helena, et al.
Publicado: (2022)

Impact of an Intravenous Trimethoprim/Sulfamethoxazole Shortage on Treatment Outcomes Among HIV-Infected Patients with Pneumocystis jirovecii Pneumonia
por: Dilworth, Thomas J., et al.
Publicado: (2014)

Successful Desensitization of T cell Flow Cytometry Crossmatch Positive Renal Transplant Recipients Using Plasmapheresis and Super High-Dose Intravenous Immunoglobulin
por: Kakuta, Yoichi, et al.
Publicado: (2017)

Pre-operative Localisation of the Parathyroid Glands in Secondary Hyperparathyroidism: A Retrospective Cohort Study
por: Hiramitsu, Takahisa, et al.
Publicado: (2019)

Preoperative Comorbidities and Outcomes of Medically Complex Living Kidney Donors
por: Hiramitsu, Takahisa, et al.
Publicado: (2019)

Hand-Assisted Laparoscopic Donor Nephrectomy in Living Donors with a History of Abdominal Surgery: A Retrospective Cohort Study
por: Hiramitsu, Takahisa, et al.
Publicado: (2021)

Long‐term prognosis in kidney transplant recipients with human T‐cell leukemia virus type 1 infection
por: Goto, Norihiko, et al.
Publicado: (2020)

Treatment of Pneumocystis jirovecii pneumonia in non-human immunodeficiency virus-infected patients using a combination of trimethoprim-sulfamethoxazole and caspofungin
por: Wu, Huan-Huan, et al.
Publicado: (2022)

Time to trimethoprim/sulfamethoxazole initiation among patients with rheumatic disease complicated by Pneumocystis jirovecii pneumonia: impact on 90-day mortality
por: Song, Siyang, et al.
Publicado: (2022)

Multicenter Study of Trimethoprim/Sulfamethoxazole-Related Hepatotoxicity: Incidence and Associated Factors among HIV-Infected Patients Treated for Pneumocystis jirovecii Pneumonia
por: Yang, Jen-Jia, et al.
Publicado: (2014)

Intact parathyroid hormone levels localize causative glands in persistent or recurrent renal hyperparathyroidism: A retrospective cohort study
por: Hiramitsu, Takahisa, et al.
Publicado: (2021)

Intraoperative recurrent laryngeal nerve monitoring using endotracheal electromyography during parathyroidectomy for secondary hyperparathyroidism
por: Hiramitsu, Takahisa, et al.
Publicado: (2021)

Intraoperative intact parathyroid hormone monitoring and frozen section diagnosis are essential for successful parathyroidectomy in secondary hyperparathyroidism
por: Hiramitsu, Takahisa, et al.
Publicado: (2022)

Hand port-site infection after hand-assisted laparoscopic donor nephrectomy for living-donor kidney transplantation: a retrospective cohort study
por: Hiramitsu, Takahisa, et al.
Publicado: (2022)

Treatment for secondary hyperparathyroidism focusing on parathyroidectomy
por: Hiramitsu, Takahisa, et al.
Publicado: (2023)

Maximal parathyroid gland diameter as a predictive factor for autograft-dependent recurrent secondary hyperparathyroidism after total parathyroidectomy
por: Hiramitsu, Takahisa, et al.
Publicado: (2023)

401. Pneumocystis jirovecii Pneumonia in Renal Transplant Recipients After a 6-Month Trimethoprim–Sulfamethoxazole Prophylaxis: A Case–Control Study
por: Park, Se Yoon, et al.
Publicado: (2018)

807. Trimethoprim/Sulfamethoxazole for Pneumocystis jirovecii pneumonia prophylaxis in B-cell lymphoma: A multicenter randomized double-blinded placebo-controlled trial
por: Angsutararux, Taksaon, et al.
Publicado: (2023)

Robotic-assisted Versus Open Technique for Living Donor Kidney Transplantation: A Comparison Using Propensity Score Matching for Intention to Treat
por: Tinney, Francis, et al.
Publicado: (2022)

The effect of maintaining high hemoglobin levels on long-term kidney function in kidney transplant recipients: a randomized controlled trial
por: Tsujita, Makoto, et al.
Publicado: (2019)

Cholecalciferol Supplementation Attenuates Bone Loss in Incident Kidney Transplant Recipients: A Prespecified Secondary Endpoint Analysis of a Randomized Controlled Trial
por: Tsujita, Makoto, et al.
Publicado: (2021)

Reliability and Validity of the Japanese Version of the Basel Assessment of Adherence to Immunosuppressive Medications Scale in Kidney Transplant Recipients
por: Kosoku, Akihiro, et al.
Publicado: (2023)

Oral/oesophageal candidiasis is a risk factor for severe infection after kidney transplantation
por: Abe, Tetsuya, et al.
Publicado: (2021)

Persistent hyperparathyroidism after preemptive kidney transplantation
por: Okada, Manabu, et al.
Publicado: (2023)

Combination therapy with trimethoprim-sulfamethoxazole and caspofungin in a case of severe pneumocystis pneumonia
por: Koshy, Robin, et al.
Publicado: (2019)

Virus-Associated Hemophagocytic Syndrome in Renal Transplant Recipients: Report of 2 Cases from a Single Center
por: Nanmoku, Koji, et al.
Publicado: (2015)

Low-dose trimethoprim-sulfamethoxazole for the treatment of Pneumocystis jirovecii pneumonia (LOW-TMP): protocol for a phase III randomised, placebo-controlled, dose-comparison trial
por: Sohani, Zahra N., et al.
Publicado: (2022)

Impact of Increased Duration of Trimethoprim-Sulfamethoxazole Prophylaxis for Pneumocystis Pneumonia After Renal Transplant
por: Chapman, Fiona A., et al.
Publicado: (2019)

Low Lymphocyte Proportion in Bronchoalveolar Lavage Fluid as a Risk Factor Associated with the Change from Trimethoprim/sulfamethoxazole used as First-Line Treatment for Pneumocystis jirovecii Pneumonia
por: Kim, Tark, et al.
Publicado: (2018)

Therapeutic Potential of Caspofungin Combined with Trimethoprim-Sulfamethoxazole for Pneumocystis Pneumonia: A Pilot Study in Mice
por: Lobo, Maria Luísa, et al.
Publicado: (2013)

Adult Living-Donor Kidney Transplantation, Donor Age, and Donor–Recipient Age
por: Hiramitsu, Takahisa, et al.
Publicado: (2021)

Elevated parathyroid hormone one year after kidney transplantation is an independent risk factor for graft loss even without hypercalcemia
por: Okada, Manabu, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_r98cci0br1resuc16n10kumu13